HKUST Receives Government’s Approval to Establish a New Medical School
Dedicated to Nurturing a New Generation of DoctorsSupporting Hong Kong Become a…
Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response…
Wells Fargo & Company Announces Common Stock Dividend
SAN FRANCISCO--(BUSINESS WIRE)--Wells Fargo & Company (NYSE: WFC) today announced its board…
Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimers Disease
In Canada, lecanemab is indicated for the treatment of adult patients with…
Cipla Health welcomes FSSAI’s new labelling rules for ‘ORS’, reinforces Prolyte ORS as the #AsliORS
MUMBAI, India, Oct. 24, 2025 /PRNewswire/ -- ProlyteORS, the flagship brand of…
Cementos Pacasmayo S.A.A. Announces Annual Dividend
LIMA, Peru--(BUSINESS WIRE)--Cementos Pacasmayo S.A.A. (NYSE: CPAC; BVL: CPACASC1) (“the Company” or…
Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia
TOKYO & HAYWARD, Calif.--(BUSINESS WIRE)--Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Arcus Biosciences,…
izmo Ltd. Receives Prestigious DSIR Recognition for In-House R&D Unit
BANGALORE, India, Oct. 16, 2025 /PRNewswire/ -- izmo Ltd., has been formally…
LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China
September 28, 2025 19:30 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE,…
Following the Appointment of Dr. Doug Buerger as COO, Jiuzi Holdings, Inc.’s Board Endorses Crypto Asset Investment Policy Allowing Up to $1 Billion Deployment
HANGZHOU, China, Sept. 24, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN;…